These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16135861)

  • 1. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription.
    Ito H; Koyama A; Higuchi T
    Br J Psychiatry; 2005 Sep; 187():243-7. PubMed ID: 16135861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia.
    Fujita J; Nishida A; Sakata M; Noda T; Ito H
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):345-51. PubMed ID: 23711166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
    Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
    Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries.
    Barbui C; Nosè M; Mazzi MA; Thornicroft G; Schene A; Becker T; Bindman J; Leese M; Helm H; Koeter M; Weinmann S; Tansella M
    Int Clin Psychopharmacol; 2006 Nov; 21(6):355-62. PubMed ID: 17012982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
    Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
    Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
    Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
    J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do psychiatrists choose among different antipsychotics?
    Hamann J; Kolbe G; Cohen R; Leucht S; Kissling W
    Eur J Clin Pharmacol; 2005 Dec; 61(11):851-4. PubMed ID: 16235042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.
    Takahashi T; Otsubo T; Kunisawa S; Sasaki N; Imanaka Y
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):224-231. PubMed ID: 32452649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.
    Kishimoto T; Watanabe K; Uchida H; Mimura M; Kane JM; Correll CU
    Psychiatry Res; 2013 Oct; 209(3):406-11. PubMed ID: 23602697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex Polypharmacy in Patients With Schizophrenia-Spectrum Disorders Before a Psychiatric Hospitalization: Prescribing Patterns and Associated Clinical Features.
    Gaudiano BA; Guzman Holst C; Morena A; Reeves LE; Sydnor VJ; Epstein-Lubow G; Weinstock LM
    J Clin Psychopharmacol; 2018 Jun; 38(3):180-187. PubMed ID: 29620698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic prescribing and its correlates in New Zealand.
    Dey S; Menkes DB; Obertova Z; Chaudhuri S; Mellsop G
    Australas Psychiatry; 2016 Aug; 24(4):360-4. PubMed ID: 26819405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the trends of polypharmacy and high-dose prescriptions in Japan.
    Shinfuku N
    Asia Pac Psychiatry; 2022 Mar; 14(1):e12488. PubMed ID: 34519433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clinicians' values and perceptions on use of clinical practice guidelines for sedation and neuromuscular blockade in patients receiving mechanical ventilation.
    Slomka J; Hoffman-Hogg L; Mion LC; Bair N; Bobek MB; Arroliga AC
    Am J Crit Care; 2000 Nov; 9(6):412-8. PubMed ID: 11072557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors.
    Leslie DL; Rosenheck RA
    Med Care; 2001 Sep; 39(9):923-33. PubMed ID: 11502950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.